C21 Investments Inc. (CXXI.CN)
CAD 0.22
(-6.52%)
CAD 0.22
(-6.52%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 11.14 Million USD | -16.8% |
| 2022 | 13.4 Million USD | -28.76% |
| 2021 | 18.8 Million USD | 0.85% |
| 2020 | 18.65 Million USD | 40.0% |
| 2019 | 13.32 Million USD | 7197.43% |
| 2018 | 182.56 Thousand USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 100.0% |
| 2013 | -119.63 Thousand USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 87.54 Thousand USD | -14.53% |
| 2010 | 102.43 Thousand USD | 52.02% |
| 2009 | 67.38 Thousand USD | -37.31% |
| 2008 | 107.48 Thousand USD | -1.81% |
| 2007 | 109.46 Thousand USD | 369.4% |
| 2006 | 23.32 Thousand USD | -18.11% |
| 2005 | 28.47 Thousand USD | 217.66% |
| 2004 | 8964.57 USD | -66.76% |
| 2003 | 26.96 Thousand USD | 1055.95% |
| 2002 | 2333.06 USD | -70.98% |
| 2001 | 8039.53 USD | 46.14% |
| 2000 | 5501.35 USD | -84.37% |
| 1999 | 35.2 Thousand USD | -59.28% |
| 1998 | 86.45 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 2.03 Million USD | 0.0% |
| 2023 Q1 | 2.71 Million USD | 64.86% |
| 2023 FY | 11.14 Million USD | -16.8% |
| 2023 Q4 | 2.84 Million USD | 3.4% |
| 2023 Q3 | 2.75 Million USD | -2.76% |
| 2023 Q2 | 2.83 Million USD | 4.08% |
| 2022 Q3 | 3.9 Million USD | 1.17% |
| 2022 Q4 | 1.64 Million USD | -57.74% |
| 2022 FY | 13.4 Million USD | -28.76% |
| 2022 Q2 | 3.85 Million USD | -3.22% |
| 2022 Q1 | 3.98 Million USD | -20.89% |
| 2021 Q4 | 5.04 Million USD | 14.71% |
| 2021 FY | 18.8 Million USD | 0.85% |
| 2021 Q1 | 5.31 Million USD | -3.72% |
| 2021 Q2 | 4.54 Million USD | -14.6% |
| 2021 Q3 | 4.39 Million USD | -3.24% |
| 2020 FY | 18.65 Million USD | 40.0% |
| 2020 Q1 | 3.23 Million USD | 2.3% |
| 2020 Q2 | 4 Million USD | 23.7% |
| 2020 Q3 | 5.88 Million USD | 46.98% |
| 2020 Q4 | 5.52 Million USD | -6.16% |
| 2019 Q1 | 2.86 Million USD | 861.73% |
| 2019 Q2 | 3.01 Million USD | 5.17% |
| 2019 Q3 | 4.28 Million USD | 42.14% |
| 2019 FY | 13.32 Million USD | 7197.43% |
| 2019 Q4 | 3.16 Million USD | -26.08% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 297.81 Thousand USD | 273.13% |
| 2018 Q3 | -172.02 Thousand USD | -400.92% |
| 2018 Q2 | 57.16 Thousand USD | 0.0% |
| 2018 FY | 182.56 Thousand USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 100.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 100.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | -119.63 Thousand USD | 0.0% |
| 2013 FY | -119.63 Thousand USD | 0.0% |
| 2012 Q1 | 3433.34 USD | 193.45% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | -6870.37 USD | -1116.12% |
| 2012 Q2 | 2818.00 USD | -17.92% |
| 2012 Q3 | 676.14 USD | -76.01% |
| 2011 FY | 87.54 Thousand USD | -14.53% |
| 2011 Q1 | 45.71 Thousand USD | -7.17% |
| 2011 Q2 | 30.04 Thousand USD | -34.27% |
| 2011 Q3 | 18.93 Thousand USD | -36.98% |
| 2011 Q4 | -3674.00 USD | -119.41% |
| 2010 Q2 | 10.07 Thousand USD | -7.5% |
| 2010 Q3 | 32.28 Thousand USD | 220.56% |
| 2010 Q4 | 49.24 Thousand USD | 52.53% |
| 2010 FY | 102.43 Thousand USD | 52.02% |
| 2010 Q1 | 10.88 Thousand USD | -76.54% |
| 2009 Q2 | 6708.00 USD | 0.72% |
| 2009 FY | 67.38 Thousand USD | -37.31% |
| 2009 Q4 | 46.4 Thousand USD | 569.25% |
| 2009 Q1 | 6660.00 USD | 64.17% |
| 2009 Q3 | 6934.00 USD | 3.37% |
| 2008 FY | 107.48 Thousand USD | -1.81% |
| 2008 Q4 | 4056.70 USD | -91.75% |
| 2008 Q3 | 49.19 Thousand USD | -53.94% |
| 2008 Q2 | 106.81 Thousand USD | 157.0% |
| 2008 Q1 | 41.56 Thousand USD | 53.2% |
| 2007 Q2 | 20.81 Thousand USD | 101.94% |
| 2007 Q4 | 27.12 Thousand USD | -13.91% |
| 2007 Q3 | 31.51 Thousand USD | 51.43% |
| 2007 FY | 109.46 Thousand USD | 369.4% |
| 2007 Q1 | 10.3 Thousand USD | 364.13% |
| 2006 Q3 | 13.09 Thousand USD | 35.98% |
| 2006 Q2 | 9630.06 USD | 3.58% |
| 2006 Q1 | 9297.54 USD | -46.53% |
| 2006 FY | 23.32 Thousand USD | -18.11% |
| 2006 Q4 | 2220.29 USD | -83.04% |
| 2005 Q4 | 17.38 Thousand USD | 62.94% |
| 2005 Q3 | 10.67 Thousand USD | 12213.93% |
| 2005 Q2 | 86.66 USD | -54.45% |
| 2005 Q1 | 190.26 USD | -93.73% |
| 2005 FY | 28.47 Thousand USD | 217.66% |
| 2004 Q4 | 3035.02 USD | 146.4% |
| 2004 Q1 | 1374.52 USD | -87.85% |
| 2004 Q2 | 2882.38 USD | 109.7% |
| 2004 FY | 8964.57 USD | -66.76% |
| 2004 Q3 | 1231.73 USD | -57.27% |
| 2003 Q1 | 1301.30 USD | 107.48% |
| 2003 Q2 | 3022.15 USD | 132.24% |
| 2003 Q3 | 11.02 Thousand USD | 264.84% |
| 2003 FY | 26.96 Thousand USD | 1055.95% |
| 2003 Q4 | 11.31 Thousand USD | 2.61% |
| 2002 Q2 | 943.87 USD | 50.28% |
| 2002 Q1 | 628.08 USD | 114.33% |
| 2002 FY | 2333.06 USD | -70.98% |
| 2002 Q4 | 627.18 USD | 446.15% |
| 2002 Q3 | 114.84 USD | -87.83% |
| 2001 FY | 8039.53 USD | 46.14% |
| 2001 Q4 | -4384.22 USD | -180.6% |
| 2001 Q3 | 5439.25 USD | -1.49% |
| 2001 Q2 | 5521.38 USD | 221.8% |
| 2001 Q1 | 1715.78 USD | 285.2% |
| 2000 Q4 | -926.44 USD | -194.9% |
| 2000 Q3 | 976.22 USD | 0.0% |
| 2000 FY | 5501.35 USD | -84.37% |
| 2000 Q1 | 7678.02 USD | 3280.85% |
| 2000 Q2 | - USD | -100.0% |
| 1999 Q4 | -241.38 USD | -108.17% |
| 1999 Q2 | 19.36 Thousand USD | 51.54% |
| 1999 FY | 35.2 Thousand USD | -59.28% |
| 1999 Q1 | 12.78 Thousand USD | 0.0% |
| 1999 Q3 | 2955.93 USD | -84.74% |
| 1998 FY | 86.45 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aion Therapeutic Inc. | -285.33 Thousand CAD | 4007.605% |
| Ayurcann Holdings Corp. | 8.46 Million CAD | -31.711% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -13138.072% |
| The BC Bud Corporation | 59.5 Thousand CAD | -18638.158% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -2895.26% |
| CordovaCann Corp. | 3.26 Million CAD | -241.028% |
| Christina Lake Cannabis Corp. | 3.46 Million CAD | -221.675% |
| Captor Capital Corp. | 16.93 Million CAD | 34.171% |
| City View Green Holdings Inc. | -290.73 Thousand CAD | 3934.988% |
| 1CM Inc. | 7.6 Million CAD | -46.54% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | -335.37 Thousand CAD | 3424.547% |
| IM Cannabis Corp. | 9.84 Million CAD | -13.242% |
| Lobe Sciences Ltd. | 772.82 Thousand CAD | -1342.727% |
| Maple Leaf Green World Inc. | -17.85 Thousand CAD | 62549.681% |
| Mountain Valley MD Holdings Inc. | -346 Thousand CAD | 3322.476% |
| Nextleaf Solutions Ltd. | 1.24 Million CAD | -793.796% |
| Ovation Science Inc. | -251.43 Thousand CAD | 4534.523% |
| Pharmadrug Inc. | -26.21 Thousand CAD | 42630.386% |
| Captiva Verde Wellness Corp. | 163.43 Thousand CAD | -6722.266% |
| RAMM Pharma Corp. | -902.83 Thousand CAD | 1334.971% |
| RIV Capital Inc. | -958.27 Thousand CAD | 1263.521% |
| Revive Therapeutics Ltd. | -328.00 CAD | 3399418.902% |
| Red White & Bloom Brands Inc. | 29.48 Million CAD | 62.185% |
| SLANG Worldwide Inc. | 18.61 Million CAD | 40.118% |
| 1933 Industries Inc. | -602.75 Thousand CAD | 1949.791% |
| Red Light Holland Corp. | 2.02 Million CAD | -451.841% |
| Top Strike Resources Corp. | 2.84 Million CAD | -291.639% |
| Xebra Brands Ltd. | -367.96 Thousand CAD | 3130.124% |
| Adastra Holdings Ltd. | 7.03 Million CAD | -58.594% |